Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
-9.24%
Shrank
—
—
Shrank
—
1 Year
Score—
Net Growth-9.24%
Net TrendShrank
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
—
-65.05%
40%
—
—
Never
—
5 Years
Score—
Net Growth-65.05%
Net Trend40%
Net Income Consistency—
Rev Growth—
Rev TrendNever
Revenue Consistency—
Monopar Therapeutics Inc fundamental performance
Across Monopar Therapeutics Inc's full reported history, from 2019 to 2025, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 4M to -$ 13M. Revenue increased in 14% of the years measured; net income in 29%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 114.90 | — |
1 Year2025-08-12 | $ 35.90 | 220.06% |
5 Years2021-08-12 | $ 24.75 | 364.24% |
All Time2019-12-19 | $ 132.50 | -13.28% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2019-12-19 |
|---|---|---|---|---|
| Price | $ 114.90 | $ 35.90 | $ 24.75 | $ 132.50 |
| Return | — | 220.06% | 364.24% | -13.28% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 14M | $ 137M |
| 2025 | $ 0.00 | -$ 13M | $ 140M |
| 2024 | $ 0.00 | -$ 15M | $ 60M |
| 2023 | $ 0.00 | -$ 8M | $ 7M |
| 2022 | $ 0.00 | -$ 10M | $ 13M |
| 2021 | $ 0.00 | -$ 9M | $ 20M |
| 2020 | $ 122.4K | -$ 6M | $ 16M |
| IPO2019 | $ 0.00 | -$ 4M | $ 13M |
Explore beyond MNPR
You're looking at Monopar Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
